What Is The Price Target For Fate Therapeutics Fate Stock Fate Q4 2025 Earnings Fate Therapeutics Inc. Posts Narrow Eps Beat No Revenue Reported 20260410 1 Snowflake Inc SNOW Valuation Disparity Widens Following GPT 55 Cortex AI Platform Integration NRXP shares rise despite NRX Pharmaceuticals reporting 361 largerthanexpected quarterly loss investors focus on future prospects APOG Apogee notches narrow Q1 2026 EPS beat shares dip 027 on muted investor reaction SPDR SP Semiconductor ETF XSD 1138 10Year Total Return Masks AI Cycle Performance Gap Vs CapWeighted Peers EasyJet Losses Deepen Amid Iran WarDriven Fuel Cost Surge and Weakened Demand Intuit Announces 17 Workforce Reduction Amid Slowing Growth and AI Disruption Concerns CCAP Q1 2026 Earnings Slight EPS Miss as Business Development Firm Maintains Steady Performance Bharti Airtel Deepens Overseas Push with Increased Stakes in Africa and UKs BT Group DIOD Q1 2026 Earnings Strong EPS Beat Masks Revenue Footprint Concerns JPMorgan Unveils 2024 Summer Reading List for Wealthy Clients AI Leadership and Lemons Take Center Stage SF Q1 2026 Earnings Stifel Financial Beats EPS Estimates by 1 Amid Mixed Market Response